Part 1: A practical approach and regulatory considerations of forced degradation studies
|Dr. Andrea Wolkerstorfer|
studied biotechnology and has over 10 years of experience in pharmaceutical research and the development of qualified biochemical and biological test systems suitable for reproducible compound testing backed by statistics and expertise in Design-of-Experiment and Quality-by-Design (QbD).
|Dr. Helmut Buschmann|
is a renowned chemist by training (IUPAC-Richter prize 2014) and has more than 20 years of experience in drug discovery and development, guided novel molecules from 15 different drug classes into